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In monocular vision, frogs display a unidirectional optokinetic horizontal nystagmus (H-OKN) 
reacting only to temporal-nasal (T-N) stimulation. The N-T component is almost absent. The analysis 
of search coil recordings after administration of dopamine into the viewing eye, the occluded eye or 
directly into the pretectum, hardly modifies the H-OKN triggered by the viewing eye irrespective of 
the concentration used. Conversely, administration of Piribedil, a strong D2 dopamine agonist, 
provokes the appearance of a N-T component, suppressing the monocular H-OKN asymmetry, 
whether the drug is injected by intravitreai or intrapretectal route. It is suggested that Piribedil could 
also bind with receptors other than dopamine's. 
Frog Optokinetic nystagmus Dopamine D2 receptor agonist 
The horizontal optokinetic reflex (H-OKN) is a visuo- 
motor reflex in which an image is stabilized on the 
retina, with respect to mow:ments of the animal or of its 
environment. It is an oscillatory pattern of eye motion 
with slow phases in the direction of the visual stimu- 
lation interrupted by rapid eye resetting fast phases in 
the opposite direction. 
Directional properties of H-OKN in monocular 
vision is one of the characteristics of this reflex. In lower 
vertebrates, monocular H-.OKN displays a directional 
asymmetry. In the frog, stimulation in the tem- 
poral-nasal (T-N) direction is the only manner to evoke 
the reflex. The nasal-temporal (N-T) stimulation is not 
able to provoke any eye movement. In previous tudies, 
an attempt to find a pharmacological explanation for the 
mechanism underlying H-OKN asymmetry was success- 
ful. Indeed, it was shown that GABAergic, cholinergic 
and glutamatergic systems are involved in this function 
and that drugs affecting these systems intervene at retinal 
as well as at central pretectal levels. 
When GABAergic and cholinergic nicotinic antagon- 
ists were injected into the viewing recorded eye, they 
provoked the abolition of the H-OKN elicited by the 
visual stimulation of this eye (Bonaventure, Jardon, 
Wioland, Y/icel & Rudol£. 1988; Y/icel, Jardon, Kim & 
Bonaventure, 1990). The,se results correlate with the 
modifications of the spatial organization of the retinal 
input observed in the same experimental conditions. 
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It was shown that GABA or ACh nicotinic antagonists 
intraocularly administrated entail the suppression of the 
inhibition exerted by the surround upon the centre of the 
ganglion cell receptive field (Bonaventure, Wioland & 
Jardon, 1986; Bonaventure, Jardon, Wioland & Rudolf, 
1987; Ariel & Rosenberg, 1991). Moreover, these 
drugs provoke the appearance of a N-T component, 
suppressing the H-OKN asymmetry when acting on 
pretectal structures, either by systemic administration, or
by microinjections directly into the pretectal nuclei 
(Yiicel, Jardon & Bonaventure, 1991; Jardon, Y/icel & 
Bonaventure, 1992; Jardon & Bonaventure, 1992). 
Moreover, dopamine found in the retina is considered 
as a neurotransmitter or a neuromodulator, with specific 
dopaminergic receptors of the D1 and D2 type (Stoof & 
Kekabian, 1984; Elena, Denis, Kosina-Boix & Lapalus, 
1989). It is synthesized in a subpopulation of amacrine 
and/or interplexiform cells (Ehinger, 1983), where both 
types of receptors are found. Mechanisms for the syn- 
thesis, the release and the uptake of dopamine are 
present in the retina, and appear to be modulated by 
light (Parkinson & Rando, 1983; Brainard & Morgan, 
1987). Acting through D1 receptors linked to the stimu- 
lation of adenylate cyclase, and possibly through D2 
receptors, dopamine induces a decrease in the per- 
meability of gap junctions between horizontal cells of 
the fish (Teranishi, Negishi & Kato, 1983) and the 
turtle (Piccolino, Witkovski & Trimarchi, 1987). Acting 
through D2 receptors linked to the inhibition of adenyl- 
ate cyclase, dopamine modulates the contractile 
machinery of photoreceptors (Dearry & Burnside, 1988; 
Vuvan, Geffard, Denis, Simon & Nguyen-Legros, 1993). 
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Moreover, the D2 receptors located on the amacrine 
cells should be involved in a negative feedback con- 
trolling the dopamine release itself (Doly, personal 
communication). 
When intravitreally injected, dopamine also induces 
changes in the receptive field properties of some 
retinal ganglion cells (Jensen & Daw, 1984). Given these 
findings, it is tempting to correlate these modifi- 
cations in spatial receptive field organization with 
possible concomitant behavioural effects on eye move- 
ments. Furthermore, it would be interesting to know 
the effects of this drug on the subcortical structures 
responsible for H-OKN (Fite, 1985). Though the localiz- 
ation of dopamine in the frog mesencephalic structures 
is still unclear, some catecholamine c lls were found 
in these nuclei, especially at mesodiencephalic junc- 
tions (Parent, Poitras & Dub6, 1984). A finer analysis 
in the pigeon (Britto, Hamasaki, Keyser & Karten, 
1989) revealed that fibres/terminals within the nBOR 
were labelled with antibodies directed against tyro- 
sine hydroxylase, the synthesizing enzyme of catechol- 
amine. 
Thus, the purpose of this study was to examine the 
effects of dopamine on frog monocular H-OKN after its 
administration, either into the viewing eye, the occluded 
eye, or directly into the pretectum by microinjection. 
A complementary study was conducted with Piribedil 
(Servier) which acts as a strong post-synaptic dopamine 
agonist (Schmitt, Laubi6, Poignant, Krikorian, Evrard, 
Freyria & Arnaud, 1978; Dourish, 1983). It is linked to 
dopamine D2 receptors, while its metabolite has a larger 
affinity for the D1 receptors. Piribedil, then, presents a
pharmacological profile "dopamine like" with a direct 
action on receptors. 
METHODS AND TECHNIQUES 
Monocular eye H-OKN was recorded in 75 frogs 
(Rana esculenta) using the magnetic field-search coil 
technique, before and after administration f the drug 
either into the viewing eye, the occluded non-recorded 
eye, or directly into the pretectum contralateral to the 
viewing eye. 
Stimulation 
The frogs were placed in an optokinetic drum 
(300 mm in dia and 450 mm in height) with alternating 
black and white vertical stripes, distributed equally on its 
inner surface (10mm wide). The drum was rotated 
clockwise and counterclockwise at constant speed by 
means of an electronic ontrol system. The range of the 
constant drum speeds used was between 1 and 9°/sec. 
Room illumination was kept constant at 801 at the level 
of the frog's eye. 
Eye OKN recording 
Eye H-OKN was recorded using a magnetic oil 
system as described by Koch (1977). One pair of coils 
(200 mm dia) carrying a current with a frequency of 
50 kHz, generates a homogenous magnetic field. These 
coils were mounted on a static platform. The sensing coil 
(1 mg, diameter of the copper wire 50/~m; inner diameter 
of the coil 2mm, 70 turns, provided by Sokymat, 
Switzerland) fixed on the eyeball and oriented perpendic- 
ularly to the inter-aural axis, was placed in the centre 
of the magnetic field. The voltage of the sensing coil, 
proportional to the sine of the horizontal angular 
displacement, was amplified, rectified, filtered and 
displayed on a paper recorder (BBC). 
The system was calibrated before each recording by 
checking the linear relationship between the sensor coil 
angular displacement and the voltage induced in the 
sensor coil. The slow eye speed was measured using the 
cumulative curve of at least hree successive slow phases 
at steady state, after elimination of the eye resetting fast 
phases. The slow phase velocity gain (the ratio between 
the slow phase speed and the drum speed) was then 
calculated. For purpose of data analysis, a Wilcoxon 
signed rank test was used. 
In order to record monocular H-OKN, the lids of one 
eye were sutured, while the sclera of the other was 
exposed by removing the superior eyelid under local 
anaesthesia (Cebesine, Chauvin Blache). The frog's head 
was immobilized by means of a nut, fixed on the skull 
and attached to a bar placed into the drum. Animals 
were also tested with no restriction of head movements. 
In this last condtion, the frog's hind legs were restrained 
by a plaster on the immobilized platform. The sensing 
coild was secured (under local anaesthesia) onthe sclera 
with a drop of glue just before the experiment. The drugs 
were prepared as described below and administered 
either intravitreally or directly into the pretectum con- 
tralateral to the viewing eye. Animals were classified in 
two groups. The first group consisted of 42 frogs, who 
underwent occlusion (by eyelid suture) of an eye l hr 
prior to recording. Animals in the second group (n = 33) 
underwent surgery (described below) and then 24 hr 
later, went through the same procedure as described 
above. 
Surgery 
Frogs were prepared the day before the experiment 
under general anaesthesia (MS 222 Sandoz). A perma- 
nent stainless-steel guide-cannula (o.d. 0.4mm; i.d. 
0.3 mm) was chronically implanted into the pretectum 
using stereotaxic procedure. The coordinates, according 
to the atlas of Wada, Urano and Gorbman (1980) were 
A/P, 0.9 mm; M/L, 0.5 mm; D/V 0.4 mm; with a head 
angle of 20 deg. The intersection of the anterior border 
of the left tectum and the sagital midline was taken as 
reference. 
The guide cannula, as well as the nut previously 
described, were anchored to the skull using retaining 
screws and dental acrylic cement. A Stainless-steel sterile 
mandrel (o.d. 0.27 mm) of the same length was inserted 
into the guide cannula to avoid obstruction. 
Unilateral microinjections were performed in awake 
animals. A stainless-steel injection cannula (o.d. 
0.28 mm; i.d. 0.18 mm) was introduced into the guide 
cannula, so that it extended 0.1 mm beyond the tip of the 
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guide cannula. The injection cannula was connected to 
1 ~tl Hamilton microsyringe via polyethylene tubing 
filled with distilled water. It was filled with the drug 
by aspiration. A small air gap separated the two 
liquids. The drug or the vehJicle was injected in a volume 
of 0.2 #1 over 20 sec. Movement of the air gap down the 
tubing was indicative of a successful administration. The 
injection cannula was left in place for an additional 
30 sec following drug administration. The mandrel was 
then replaced into the guide cannula. 
Histology 
To ascertain the injection site (Fig. 1), frogs were 
deeply anaesthetized in MS222 following 8 days of 
post injection survival time. After transcardiac perfusion 
with 0.9% saline followed by 4% formalin, brains 
were removed and placed into a 4% formalin solution. 
Paraffin embedded brains were cut in 20 #m slices and 
processed with cresyl-violet stain. All the animals in 
which the cannula track could not be clearly localized 
were excluded from the study. 
Drugs 
Dopamine HCI (Sigma) was dissolved in saline and 
protected from oxidization by adding 0.1% sodium 
ascorbate (buffered to pH 7.4 with diluted HCI). This 
vehicle was injected as a control. Piribedil (Servier) 
was diluted in saline. The volume of the intraocular 
injections was 30 #1. The concentrations u ed for each 
drug were determined from past studies and from pilot 
studies. The concentration of dopamine was 50/zM 
when injected into the viewing recorded eye, 0.1 or 
50 mM when injected into the occluded eye and 0.1 or 
10 mM when administered irectly into the pretectum 
(in this last case the quantity was, respectively, 3.79 and 
379 ng/0.2 #1). 
As for Piribedil, the concentration was 10mM 
when injected into the viewing recorded eye, 1 and 
10 mM when injected into the occluded eye, and 0.1 or 
1 mM when administrated directly into the pretectum 
(in this last case the quantity was respectively 7.84 and 
78.4 ng/0.2/tl). 
RESULTS 
Control conditions 
The H-OKN was recorded in each animal, before 
injection, at four different drum speeds and in both 
directions of stimulation. In these conditions, the view- 
ing eye predominantly followed the stripes moving in 
the T-N direction (n = 75). When the stimulation was 
applied in the N-T  direction, no eye movement was 
detected, irrespective of the drum speed tested. Injection 
of the vehicle (saline and ascorbate) did not change 
the H-OKN gain when administered either into the eye 
(n = 3) or into the pretectum (n = 3). Additionally, 
surgical cannula implanted into the pretectum did not 
modify the control H-OKN. 
Monocular eye H-OKN recordings following intraocular 
administration of dopamine into the viewing eye 
No spontaneous eye movement was observed after 
dopamine injection. The H-OKN recording started 
15 min after drug administration. 
After intravitreal injection of dopamine 50mM 
(n = 5) into the viewing eye, the recording OKN was 
mildly changed: the slow phase velocity gain of the T-N 
component was not modified (P > 0.5) compared to that 
FIGURE 1. Photomicrograph showing acoronal section (20/am) of the mesodiencephalic region of the frog. The tip of the 
cannula track represents the site of injection and is located medially to the anterior part of the optic tectum in the nucleus 
Lentiformis Mesencephali. 
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F IGURE 2. Mean values of slow phase velocity gain of monocular eye OKN before (open symbols) and following unilateral 
injection of dopamine (solid symbols) into the open recorded eye (A), the occluded eye (B) or the pretectum (C) (dopamine 
0.1 mM), and (D) (dopamine 10 mM). The vertical bars indicate the SD. 
of the control [Fig. 2(A)]. The only difference was 
observed in the resetting fast phase frequency which was 
slightly, but significantly decreased, at least for the 
highest drum speeds (6 and 9 deg/sec) [Fig. 3(A)]. For 
instance, from 6.75 beats/20 sec before injection, it was 
reduced to 4 beats/20 sec after dopamine for a constant 
stimulation speed of 9 deg/sec. But this effect was revers- 
ible since 2 hr later, the fast phase frequency had totally 
recovered its initial value. 
The stimulation i  the N-T direction remained unable 
to provoke the reflex and the slow phase velocity gain 
was nil. 
Monocular eye H-OKN recordings following intraocular 
administration of dopamine into the occluded eye 
The results were identical to those obtained when the 
drug was injected into the viewing eye. 
After injection ofdopamine 50 mM (n = 6) or 0.1 mM 
(n = 4) the OKN was weakly modified [Fig. 2(B)]. The 
slow phase velocity gain of the T-N component was not 
significantly modified compared to the control, at any 
drum speed or drug concentration used. As observed 
in the previous experiment, in this experimental con- 
dition, the fast phase frequency was reduced, especially 
for the highest stimulation speeds. At a 6 deg/sec drum 
speed, the fast phase frequency, which had reached 6.2 
beats/20 sec previously, was reduced to 3.5 beats/20 see 
following injection of both dopamine concentrations 
used [Fig. 3(B)]. Stimulations in the N-T direction 
remained unable to provoke the reflex. 
Monocular eye H-OKN recordings following 
microinjections of dopamine into the pretectal nuclei 
contralateral to the viewing eye 
Monocular eye H-OKN recording started immedi- 
ately after drug administration. No spontaneous eye 
movement was observed after injection. 
Intrapretectal microinjections of dopamine 0.1 mM 
(n=9)  or 10mM (n=5)  did not induce changes in 
monocular H-OKN. The N-T component did not occur. 
The slow phase gain measured from the T-N component 
was slightly but significantly increased (P > 0.01) for 
all the stimulation speeds after injection of dopamine at 
the 0.1 mM concentration [Fig. 2(C)]. It increased for the 
two lowest stimulation speeds only, at the 10 mM con- 
centration [Fig. 2(D)]. The fast phase frequency did not 
appear to be reduced [Fig. 3(C)]. However, examination 
of the post-injection data clearly indicates an increase in 
eye movement magnitude. Indeed, some frogs without 
head restriction, displayed very ample head (gaze) move- 
ments in the T-N direction (Fig. 4). These movements 
were not spontaneous. They appeared only in response 
to a T-N stimulation. They were never observed when 
dopamine was injected into the eye. 
Monocular eye H-OKN recordings following intraocular 
administration of Piribedil into the viewing eye 
After intravitreal injection of Piribedil 10 mM (n = 7) 
into the viewing eye, no spontaneous eye movement was 
observed. 
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FIGURE 3. Mean values of fast phase frequency (beats/20 sec) of 
monocular eye OKN before (open symbols) and following unilateral 
injection of dopamine (solid symbols) into the open recorded eye (A), 
the occluded eye (B) or the pretectum (C). The vertical bars indicate 
the SD. 
For a T -N stimulation, no change was noticed in 
the monocular horizontal eye H-OKN when compared 
to that recorded before injection. The average velocity 
gain did not change significantly from the control value 
(P > 0.5) for all the drum speeds tested. 
But, for a N-T  stimulation, the frogs displayed an eye 
H-OKN with slow phases following the alternating 
black/white vertical stripe motion, and resetting fast 
phases which were not observed in controls. The average 
velocity gain increased significantly for all the drum 
speeds tested (P <0.05) [Fig. 5(A)]. The H-OKN 
became almost symmetrical with the presence of both the 
T -N  and N-T  component,; relative to the stimulated eye 
in monocular vision. The difference between the velocity 
gain of eye OKN evoked by a T -N  stimulation 
and that evoked by a N-T  stimulation which was 
significant before injection (P < 0.005), was no longer 
significant after Piribedil administration (P > 0.2). The 
N-T  component was still present 5 hr after injection of 
Piribedil. 
Monocular eye H-OKN recordings following intraocular 
administration of Piribedil into the occluded eye 
After injection of Piribedil 10 mM (n = 12) or 1 mM 
(n = 5) into the occluded eye, no spontaneous movement 
was elicited. 
During T -N  stimulation, no change could be recorded 
in the eye OKN velocity gain for all drum speeds 
tested (P >0.2) and for both drug concentrations 
[Fig. 5(B)]. 
For a N-T  stimulation, frogs displayed an eye 
OKN with slow and fast phases, contrary to what was 
recorded before injection. The difference between the 
OKN velocity gain evoked by a T -N  stimulation and 
that evoked by a N-T  stimulation was no longer signifi- 
cant (P > 0.1). These effects proved to be reversible, less 
than 24hr after injection, the N-T  component had 
completely disappeared. 
Monocular eye H-OKN recordings following 
microinjections of Piribedil into the pretectal nuclei 
contralateral to the viewing eye 
Immediately after the end of the administration of 
Piribedil 0.1 mM (n = 12) or 1 mM (n =4)  frogs not 
only followed stripes in the T-N direction, but also 
those moving in the N-T  direction. Both types of 
phase, slow and resetting fast phases were observed for 
both directions of stimulation [Fig. 5(C,D)]. The 
H-OKN recorded in T -N  direction was not modified 
compared to that recorded before injection. This was 
evident in the number of fast phases which was not 
reduced. Moreover, ample head movements were not 
observed although they began to occur after dopamine 
administration. 
The slow phase velocity gain of the T -N  component 
was not significantly modified compared to that of the 
controls. But there was a significant increase (P < 0.005) 
in gain for the N-T  stimulation for the four drum speed 
tested (Fig. 5) after Piribedil at both concentrations, 
while the gain was almost nil for the stimulation before 
injection. 
DISCUSSION 
In monocular viewing conditions, frogs displayed an 
asymmetrical H-OKN which was present only for stimu- 
lations in the T -N  direction and not for those in the N-T  
direction. Dopamine, irrespective of its injection site 
(eye or pretectum) did not modify this asymmetry and 
the N-T  component did not appear. 
The recorded monocular H-OKN remained identical 
whether dopamine was intravitreally injected into the 
viewing eye or into the occluded one. This fact suggests 
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FIGURE 4. Coil recording of gaze OKN, evoked by a T-N stimulation at constant drum speeds in moncular viewing 
conditions in a control animal (A) and following unilateral injection of dopamine into the pretectum (B). The drum speeds 
are indicated on the left of each recording. Calibration: the vertical bar corresponds to an angular displacement of 5 deg and 
the horizontal bar indicates a duration of 10 sec. 
that the effects of the drug observed at the retinal 
level on ERG (personal observations) or on ganglion 
cell receptive fields (Negishi & Drujan, 1979; Mangel 
& Dowling, 1985; Jensen & Daw, 1984) have only 
few repercussions on the retinal output at the origin 
of the H-OKN slow phases. Thus, dopamine, which 
in the retina modulates the plasticity of horizontal cell 
structure and function, and which is involved, like 
GABA and ACh, in spatial organization of ganglion 
cell receptive field, does not seem to be involved in 
H-OKN genesis. This observation suggests that the 
hypothesis of a direct relationship between ganglion cell 
receptive field properties and behavioural drug effects is 
not totally correct. In view of these results and previous 
ones, the role of the retinal output upon OKN asymme- 
try would be related to the directional sensitivity of 
ganglion cells, which itself is controlled by GABAergic 
and cholinergic systems but not by a dopaminergic 
mechanism. 
When intravitreally injected, dopamine slightly re- 
duced the resetting fast phase frequency, especially at the 
highest drum speeds. This was not observed when the 
drug was injected directly into the pretectum. This 
difference could be explained if, as we showed (Yiicel, 
Jardon & Bonaventure, 1989), some characteristics of
the resetting fast phases originate in the retina. 
Moreover, when administered into the pretectum 
dopamine provoked the appearance of head and eye 
movements of very large amplitude, when the head was 
free. In this gaze OKN, inputs from the retina and 
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FIGURE 5. Mean values of slow phase velocity gain of monocular eye OKN before (open symbols) and following unilateral 
injection of Piribedil (solid symbols) into the open recorded eye (A) the closed eye (B) or the pretectum (C) (Piribedil 0.1 mM), 
and (D) (Pirib&lil 1 mM). The vertical bars indicate the SD. 
semi-circular canals interact with the neck propriocep- 
tors in a complex system. However, it is difficult to 
understand how dopamine could act on neck proprio- 
ception receptors, given our experimental condition. 
A startling effect with Piribedil was observed, which 
differed significantly from that obtained with dopamine. 
Piribedil has provoked the appearance of a N-T com- 
ponent, suppressing the OKN asymmetry, when injected 
either into the viewing eye, the occluded eye or directly 
into the pretectum. This effect was never observed after 
dopamine administration,, irrespective of the concen- 
tration used. 
However it may be noted that the amplitude of the 
ERG b-wave was decreased in the same manner follow- 
ing intraocular injection of  either Piribedil or dopamine 
at the concentrations used in behavioural experiment 
(personal observations, Doly, 1990). 
Piribedil is accepted as a strong dopamine agonist on 
D2 receptors (Schmitt et al., 1978) while dopamine acts 
on D 1 as well as on D2 receptors. It can be considered, 
as proposed by Doly (personal communication), that 
dopamine could act in opposite way upon D1 and D2 
receptors, and that its action upon the D1 receptors 
could cancel the effects ,an the D2 ones. Or, rather, 
should we consider the possibility that Piribedil displays 
characteristics other than "dopamine-like" and could 
be linked to other receptors? One probable system 
involved in the Piribedil effect is the cholinergic 
muscarinic system. 
Piribedil, like other dopaminergic agonists, exerts a 
negative feedback upon the cholinergic activity at the 
nigrostriatal level. Dopamine, released by the dopamin- 
ergic terminals activates dopaminergic receptors located 
on cholinergic neurons in the striatum, inhibiting cholin- 
ergic transmission. But, this anticholinergic effect is not 
direct and intervenes through dopaminergic receptors. 
Consequently, this mechanism cannot be involved in the 
effect of Piribedil on OKN presented here. It was also 
shown that Piribedil slowed down the neural conduction 
in the cholinergic neuron of the cockroach (Chanelet & 
Pelhate, 1975). In this study, it is not known whether 
Piribedil acts directly upon the cholinergic receptors or 
through the dopaminergic system. However, binding of 
Piribedil on muscarinic receptors has been observed 
(Kato, 1991): Piribedil displaced 3H-Pirenzepine (an M 1 
ligand) from its binding sites. Even if this effect is 
relatively weak, it suggests that Piribedil could have a 
direct effect upon cholinergic receptors in addition to 
its cholinergic activity via dopaminergic receptors. 
Nevertheless this weak affinity for the muscarinic recep- 
tor (IC50:3.6 x 10 -5 M) is in the range of the affinity of 
the "first generation" of ACh muscarinic ligands, i.e. 
muscarine and scopolamine. Like Piribedil, muscarine 
provoked the appearance of a N-T component at the 
same range of concentrations than those of Piribedil 
(Jardon & Bonaventure, 1992). 
The fact that Piribedil could bind cholinergic receptors 
is not totally surprising, since it displays structural 
chemical analogies with ACh. Moreover, it is well 
known that drugs interfering with amine neurotransmit- 
ter systems and using protein G as a second messenger, 
have some common effects on the receptor membrane. 
In the same manner, Piribedil has a preferential binding 
with, at least, two types of receptors with different 
B. JARDON and N. BONAVENTURE 
ities. In the dopaminergic system, Piribedil 
s with the D2 receptors without effecting D1 recep- 
1 these data suggest hat Piribedil could act, in our 
el, as a muscarinic agonist. But this hypothesis must 
,nfirmed by studying the effects of Piribedil on OKN 
I dopamine D2 or muscarinic receptors are blocked. 
minary results gathered in our laboratory suggest 
this may indeed be the case. 
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